Sick leave duration capped at one month for first prescription
Executive summary: The French government published a decree limiting sick‑leave duration to one month for first prescriptions and two months for extensions, effective 1 September 2026. The policy seeks to reduce social‑security expenditures and balance employer cost pressures while potentially affecting employee leave rights.
Who is involved: French Ministry of Health, Social Security administration, employer federations, labour unions.
Likely next: Implementation will be monitored, with possible legal challenges and adjustments before the September start date.
The French government published a decree limiting sick‑leave duration to one month for a first prescription and two months for extensions, effective 1 September 2026. The measure is part of the 2026 Social Security financing law and aims to curb rising benefit costs while addressing employer concerns. Reactions range from employer support for cost control to union concerns about employee rights.
Timeline
- — Les durées des arrêts de travail limitées à partir du 1er septembre (Le Figaro — Économie)
- — Congé de naissance, télétravail, journées écourtées: les «bons pères» peuvent-ils encore faire carrière? (Le Figaro — Économie)
- — Arbeitsmarkt: Deutschland drohen bis 2036 rund 4,3 Millionen fehlende Arbeitskräfte (Der Spiegel — Wirtschaft)
Analysis — what this means
Likely next events
- Government monitors implementation before 1 September rollout
- Employers adjust HR policies regarding sick‑leave tracking
Sectors affected
- Healthcare
- Human Resources
- Labor Law
Regulatory implications
- Increased compliance for employers
- Oversight by Social Security agency
Historical parallels
- 2008 French sick‑leave reform
- 2013 French decree limiting short‑term benefits
- EU work‑life balance directive
Sources
Open the full interactive case file on Beyond →